Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Combination of Radiotherapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High and Intermediate Risk Localized Prostate CancerInt. J. Radiat. Oncol. Biol. Phys 2020 Nov 28;[EPub Ahead of Print], BF Koontz, KE Hoffman, S Halabi, P Healy, M Anand, DJ George, MR Harrison, T Zhang, WR Berry, PG Corn, WR Lee, AJ Armstrong
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.